SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-026870
Filing Date
2024-03-06
Accepted
2024-03-06 07:19:17
Documents
6
Effectiveness Date
2024-03-06

Document Format Files

Seq Description Document Type Size
1 S-8 itos_march_2024_evergree.htm S-8 80832
2 EX-5.1 itos-ex5_1.htm EX-5.1 11450
3 EX-23.1 itos-ex23_1.htm EX-23.1 3855
4 EX-FILING FEES itos-exfiling_fees.htm EX-FILING FEES 22964
5 GRAPHIC img169804041_0.jpg GRAPHIC 10448
6 GRAPHIC img169804041_1.jpg GRAPHIC 26462
  Complete submission text file 0000950170-24-026870.txt   171329
Mailing Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472
Business Address 321 ARSENAL STREET BLDG 312, FLOOR 3, SUITE 301 WATERTOWN MA 02472 857-204-4583
iTeos Therapeutics, Inc. (Filer) CIK: 0001808865 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277687 | Film No.: 24724367
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)